ArticleRheumatology (Oxford, England)2022

Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.

Julia Spierings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.